|
|
||||||||
and
Differentially Regulate Death-Inducing Signaling Complex Formation in Cigarette Smoke Extract-Induced Apoptosis1








* Department of Pulmonary and Critical Care Medicine, Gachon Medical School, Gil Medical Center, Inchon, Republic of Korea;
Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh Medical Center,
Center for Biologic Imaging, Department of Cell Biology and Physiology, School of Medicine, University of Pittsburgh;
Division of Pediatric Hematology-Oncology, Childrens Hospital of Pittsburgh, Pittsburgh, PA 15213;
¶ Institute of Molecular Oncology, Showa University, Tokyo, Japan; and
|| Division of Pulmonary and Critical Care Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, MA 02115
| Abstract |
|---|
|
|
|---|
,
,
, and
, were activated by CSE exposure. Overexpression of wild-type PKC
inhibited, while PKC
promoted, CSE-induced cell death. Dominant-negative (dn)PKC
protected against CSE-induced cell death by suppressing DISC formation and caspase-3 activation, while dnPKC
enhanced cell death by promoting these events. DISC formation was augmented by wortmannin, an inhibitor of PI3K. CSE-induced Akt phosphorylation was reduced by dnPKC
, but it was increased by dnPKC
. Expression of PKC
in vivo inhibited DISC formation, caspase-3/8 activation, lung injury, and cell death after prolonged cigarette smoke exposure, whereas expression of PKC
promoted caspase-3 activation. In conclusion, CSE-induced DISC formation is differentially regulated by PKC
and PKC
via the PI3K/Akt pathway. These results suggest that modulation of PKC may have therapeutic potential in the prevention of smoke-related lung injury. | Introduction |
|---|
|
|
|---|
stimulation in vascular smooth muscle cells (18, 19) or in mesenchymal cells (18). Furthermore, we have previously demonstrated that both Fas and caspase-8 associate with the Golgi complex-associated protein, GRASP65, in mouse lung endothelial cells subjected to hypoxia/reoxygenation stress (20). However, nothing is known to date about CSE-induced DISC formation, its regulation, or subcellular trafficking.
The protein kinase C (PKC) family is responsible for transducing many cellular signals during cell death. The PKC family consists of at least 12 broadly expressed serine/threonine kinase isoforms that have been divided into three subgroups based on their regulation: the conventional PKCs (
, βI, βII, and
), the novel PKCs (
,
,
, µ, and
), and the atypical PKCs (
,
, and
) (21). Each PKC isoform is expressed by an individual gene, except for βI and βII. PKCs are expressed in a tissue-specific manner and respond to activation by distinct stimuli (22). Differential roles of PKC in apoptosis have been reported depending on specific isoforms, cell types, and/or stimuli. For example, PKC
potentiated Fas-mediated apoptosis in T cells (23). Thrombin-induced resistance to apoptosis in normal lung fibroblasts involved PKC
but not PKC
(24). At present, little is known about the role(s) of PKC in CSE-induced apoptosis and in the regulation of DISC formation. We hypothesized that DISC formation represents a critical event in the CSE-induced apoptotic pathway, and that CSE-induced DISC formation may be regulated by specific PKC isoforms.
In the present study, using human lung fibroblasts (MRC-5), we investigated the assembly and subcellular trafficking of the DISC in response to CSE exposure. To elucidate the proximal events in Fas signaling, we examined how specific PKC isoforms regulate CSE-induced DISC formation. In MRC-5 cells exposed to CSE, we demonstrate that the DISC formation occurs initially in the Golgi complex, which precedes its accumulation in the plasma membrane. We show for the first time that distinct PKC isoforms, PKC
and PKC
, differentially regulate CSE-induced DISC formation, caspase-8/caspase-3 activation, and cell death in lung fibroblasts. Furthermore, PKC
and PKC
differentially modulate apoptosis in vivo in response to chronic cigarette smoke exposure.
| Materials and Methods |
|---|
|
|
|---|
Abs against Fas, caspase-3 PKCs, and GRASP65 were from Santa Cruz Biotechnology. Anti-caspase-8 Ab and anti-human CD95 (anti-Fas) mAb CH11 were from BD Pharmingen. For fluorescent images, affinity-purified secondary Abs and species-absorbed conjugates (FITC488, Cyr3, and Cyr5) for multiple labeling were from Chemicon International. All other chemicals were from Sigma-Aldrich.
Adenovirus-mediated gene transfer
Replication-deficient Ad5-type adenovirus vectors containing the cDNA of both wild-type and kinase-negative mutants of rabbit PKC
and mouse PKC
were constructed as described previously (25).
Preparation of CSE
Kentucky 1R3F research-reference filtered cigarettes (The Tobacco Research Institute, University of Kentucky, Lexington, KY) were smoked using a peristaltic pump (VWR International). Before the experiments, the filters were cut from the cigarettes. Each cigarette was smoked in 6 min with a 17-mm butt remaining. Four cigarettes were bubbled through 40 ml of cell growth medium, and this solution, regarded as 100% strength CSE, was adjusted to a pH of 7.45 and used within 15 min after preparation.
Cell culture and treatments
The MRC-5 were cultured in DMEM containing 10% FBS, in humidified incubators at 37°C. For adenoviral transfections, cells were grown to 30% confluence and changed to serum-free medium containing 106 CPU/ml of an adenoviral vector inserted with wild-type or dominant negative (dn)PKC
, PKC
, or LacZ. Infected cells were incubated for 3 h, then restored to normal DMEM medium containing 10% FBS for an additional 2 days incubation. For CSE treatment, the MRC-5 were grown to 90% confluence and restored to fresh medium. MRC-5 were also treated with 100 ng/ml anti-human CD95 (anti-Fas) mAb as a positive control. Fas–/– fibroblasts were harvested from the lungs of MRL-Fas lpr/J mice (stock no. 000480) (The Jackson Laboratory), according to previously described protocols (26).
Cytotoxicity and viability assays
Lactate dehydrogenase (LDH) release was measured using a cytotoxicity detection kit (Roche Molecular Biochemicals), according to the manufacturers protocol. After gentle agitation, 200 µl of culture medium was removed at various times for the assay. For colorimetric MTT assay, MRC-5 cultured in DMEM containing 10% FBS were treated with CSE after adenoviral infection. After incubation for the indicated time, the culture medium was removed and 20 µl of 5 mg/ml MTT was added. Four hours later, the supernatant was discarded and 100 µl DMSO was added to each well. The mixture was shaken and measured at 595 nm using a ELx800 universal microplate reader (BioTek Instruments).
Cell fractionation
Total membrane fraction was isolated as described previously (27). MRC-5 were harvested in MB buffer (20 mM HEPES (pH 7.5), 1.5 mM MgCI2, 10 mM KCl, 1 mM EDTA, 1 mM dichlorodiphenyltrichloroethane, 250 mM sucrose) containing protease inhibitors and homogenized in a 1.5-ml Dounce homogenizer. Nuclei and unbroken cells were removed by centrifugation for 10 min at 500 x g, and the supernatants were centrifuged at 100,000 x g for 60 min at 4°C. The resulting pellet contained total cellular membranes.
The lipid rafts fraction was isolated as described previously (28). MRC-5 were harvested and homogenized in MBS (25 mM 2-N-morpholinoethanesulfonic acid (pH 6.5), 0.15 M NaCl) containing 1% Triton X-100. Homogenates were adjusted to 40% sucrose by the addition of 2 ml of 80% sucrose prepared in MBS and placed at the bottom of an ultracentrifuge tube. A 5–30% discontinuous sucrose gradient was formed above (4 ml of 5% sucrose/4 ml of 30% sucrose, both in MBS lacking detergent) and centrifuged at 39,000 rpm for 18 h in a SW41 rotor (Beckman Instruments). A band at the interface of 5 and 30% sucrose was collected and used for immunoprecipitation and Western blot.
The Golgi complex was isolated using sucrose density gradient centrifugation, as described previously (20). After washing with PBS, the cells were harvested in G buffer (10 mM Tris-HCI, 0.25 M sucrose, 2 mM MgCI2 (pH 7.4)) containing 10 mM CaCI2 and protease inhibitors. The cells were disrupted with 20 strokes in a Potter-type homogenizer. The homogenate was centrifuged at 2500 x g for 10 min and the pellet was discarded. The resulting postnuclear supernatant was harvested and the sucrose concentration adjusted to 1.4 M final concentration. This suspension was loaded onto the bottom of an ultracentrifuge tube and overlaid in succession with 1.2, 1.0, and 0.8 M of sucrose in G buffer. Samples were then centrifuged at 95,000 x g for 2.5 h. Two bands from the top, representing 0.8/1.0 and 1.0/1.2 M interfaces, were carefully removed and diluted with G buffer without sucrose, collected by centrifugation at 80,000 x g for 30 min, and used for the experiments.
Immunoprecipitation and Western blot analysis
Proteins were isolated from the culture of MRC-5 with radioimmunoprecipitation assay (RIPA) buffer (1x PBS, 1% (v/v) Nonidet P-40, 0.5% (w/v) sodium deoxycholate, 0.1% (w/v) SDS, 0.1 mg/ml PMSF, 30 µl/ml aprotinin, 1 mM sodium orthovanadate). For immunoprecipitation, 1 µg of anti-Fas Ab was added to 500 µg of total protein in 500 µl, rotated for 2 h at 4°C, then incubated with 20 µl of protein A-sucrose beads (Santa Cruz Biotechnology) for another 2 h, spun down at 500 x g, and washed three times with RIPA buffer. Next, 20 µl of loading buffer (100 mM Tris-HCl, 200 mM DTT, 4% SDS, 0.2% bromophenol blue, 20% glycerol) was added. SDS-PAGE and Western Immunoblot analysis were then performed.
Caspase activity assays
Caspase-3 fluorogenic substrate, Ac-DEVD-AFC, was from BD Biosciences. Caspase activity in cell lysates was determined according to the manufacturers instructions, using an Aminco-Bowman series-2 spectrofluorometer (440/500-nm excitation/emission), and expressed as fold increase of caspase-3 activity over control.
Immunofluorescent cell imaging
Based on the Nomarsky images, MRC-5 cells were selected for fluorescent analysis in the same focal plane. Immunofluorescent-labeled cells were analyzed after fixing at the indicated time points, as previously described (29). In all experiments, a Zeiss upright research microscope with Everest digital microscopy workstation, which uses the SlideBook image acquisition and processing software (Intelligent Imaging Innovations), was used. Images were obtained in two-dimension (x–y-axis) and processed using Photoshop 7.0 software (Adobe Systems).
Immunohistochemistry
The smoked mouse lung sections were fixed in 10% formaldehyde for 24 h and processed for paraffin embedding. To perform the immunohistochemistry, paraffin-embedded tissues were deparafinized in xylene, rehydrated, retrieved, and immunostained with anti-Fas and anti-caspase-8 (Santa Cruz Biotechnology). The positively staining area, brown in color, was determined against the negatively staining region, shown relatively as blue in color.
In vivo cigarette smoke exposure
Animals were housed according to guidelines from the American Association for Laboratory Animal Care and Research Protocols and were approved by the Animal Care and Use Committee (University of Pittsburgh School of Medicine). Male, age-matched C57BL/6 strain mice (The Jackson Laboratory) were exposed to CS or filtered air under identical conditions beginning at 8 wk of age. Total-body CS exposure was performed in a stainless steel chamber (71 x 61 x 61 cm) using a smoking machine (Model TE-10, Teague Enterprises), similar to that reported by others (30). The smoking machine puffs each 1R3F cigarette for 2 s, for a total of 9 puffs before ejection, at a flow rate of 1.05 L/min, providing a standard puff of 35 cm3. The smoke machine was adjusted to deliver 5 cigarettes at one time. Mice were exposed 5 days/week for up to 24 wk. The chamber atmosphere was periodically measured for total particulate matter concentrations of 100–120 mg/m3. Carboxyhemoglobin levels in the C57BL/6 strains of mice after 2 wk of cigarette exposure were <8% immediately following exposure.
For adenoviral infections, 1 x 1011 virus particles of each virus (PKC
, PKC
, or LacZ) in 50 µl of saline were administered intratracheally to each mouse before the initiation of cigarette smoke exposure. Lung injury was assessed by H&E staining. TUNEL staining of lung tissue sections was performed with a reagent kit (ApO-BrdU, Invitrogen) and detected by confocal microscopy.
Statistical analysis
All values are expressed as means ± SE. Statistical significance was determined by Students t test, and a value of p < 0.05 was considered significant.
| Results |
|---|
|
|
|---|
DISC formation represents the most proximal event in the Fas-mediated extrinsic apoptotic pathway (15). We evaluated the DISC formation at both the population and single-cell levels by biochemical and fluorescent imaging analysis. First, we examined the kinetics of DISC formation as a function of CSE exposure in MRC-5 cells. MRC-5 cells were treated with 20% CSE for 0, 1, 3, and 6 h. Cell lysates were immunoprecipitated with anti-Fas and immunoblotted with anti-caspase-8 (p43/41) to detect DISC formation. The DISC formed maximally at 1 h and then declined to background levels by 6 h (Fig. 1A). The total level of Fas was unaltered by CSE treatment at the various exposure times (0–6 h), and therefore it was used as a loading control along with IgG (Fig. 1A). In a dose-response experiment, maximum DISC formation was observed after 1 h exposure to CSE concentrations of 10–20%, but it was diminished at higher concentrations of CSE (>30%) (Fig. 1B). Next, we examined DISC formation in single cells using immunofluorescence microscopy. MRC-5 cells were double-labeled with a rabbit anti-Fas polyclonal Ab (blue) and mouse anti-caspase-8 mAb (green) after exposure to 20% CSE for 0, 15, 30, 60, and 180 min (Fig. 1C). The images show a time-dependent increase in CSE-induced DISC formation in individual cells, as evidenced by the cyan pseudocolor resulting from the colocalization of Fas (blue) and caspase-8 (green). CSE treatment of MRC-5 resulted in the time-dependent increase in DISC-positive cells. Consistent with the above biochemical studies, the single-cell image studies demonstrated maximum DISC formation at 1 h CSE exposure with 59% (n = 49) of cells displaying DISC formation at this time (Fig. 1C).
|
|
We also evaluated the activation of caspase-8 as a function of CSE exposure, because DISC formation triggers the proteolytic autoactivation of caspase-8, which in turn activates downstream caspase-1 and caspase-3. After exposing MRC-5 to 20% CSE for 0, 1, 3, 6, and 12 h, cell lysates were immunoblotted with anti-caspase-8. There was a clear increase in the appearance of the cleaved active caspase-8 p18 subunit after 3 h of CSE exposure (Fig. 2E). Caspase-3 is an executioner caspase, the activation of which represents a distal event in apoptosis-signaling pathways. Caspase-3 is normally present in an inactive proenzyme form, but it can be activated by proteolytic processing of its inactive zymogen into its cleaved p17 and p19 forms. There was a clear expression of the cleaved caspase-3 subunit p19 after 6 h of CSE exposure (Fig. 2E). Collectively, these results indicate that CSE exposure induced MRC-5 cell death in a time- and dose-dependent manner, and that this cell death is dependent on the activation of the Fas/caspase-8 signaling pathway.
We also examined Fas and caspase-8 expression in the lung sections from mice that were exposed to CS, 5 days per week for 24 wk with each exposure for an average of 3 h. The smoke treatment conditions were designed to mimic passive smoke exposure of humans in whole-body exposure chambers. As shown in Fig. 2F, immunohistochemical staining of lung tissue sections of CS-exposed mice displayed increased inflammatory cell content, including alveolar macrophages, emphysematous dilatation, and increased expression of Fas and caspase-8 in alveolar macrophages and septal wall cells, relative to lungs from sham-treated mice. These results support the notion that Fas-dependent cell death may occur as a component of tissue injury during in vivo CS exposure.
Subcellular trafficking of DISC in CSE-induced apoptosis
We examined the subcellular localization of the DISC in MRC-5 cells in response to CSE. MRC-5 cells were fractionated to isolate Golgi complex, or membrane lipid rafts and immunoprecipitation studies were performed to identify the DISC. As shown in Fig. 3A, the DISC formed as early as 30 min after treatment with 20% CSE in the Golgi fractions. The level of Golgi-associated DISC declined thereafter in a time-dependent manner. In contrast to that of the Golgi complex, the level of DISC formation in the lipid rafts increased in a time-dependent manner following CSE exposure (Fig. 3A). We next analyzed DISC formation in response to 20% CSE exposure at the single-cell level using immunofluorescence microscopy. MRC-5 cells were triple-labeled with Fas, caspase-8, and GRASP65, a marker of Golgi (31) as shown in Fig. 3B. In the steady state, Fas and caspase-8 were present in both the Golgi and extra-Golgi subcellular compartments, predominantly demonstrating a nonoverlapping distribution (Fig. 3B). After 3 h, although Fas and caspase-8 were still detected inside the Golgi, the DISC, identified by the yellow pseudocolor from the overlap of red and green, was formed outside the Golgi complex in 40% of CSE-treated cells (n = 35) (Fig. 3B, top panels). The DISC as indicated by cyan pseudocolor (Fig. 3B, bottom panels) was associated with the lipid rafts in 42% of cells examined (n = 41). The results show that the DISC is preformed in the Golgi complex and translocated to the plasma membrane during CSE exposure.
|
Because PKC has emerged as a potent regulator of apoptotic pathways, we evaluated the effect of PKC on the extrinsic apoptotic pathway induced by CSE, mainly focusing on DISC formation. First, we investigated whether CSE can alter the expression or activation of PKC isoforms in MRC-5 cells by Western immunoblotting of cell lysates. The total expression of PKC
and PKC
was not altered in response to exposure to 20% CSE (Fig. 4A). The expression level increased in PKC
and decreased in PKC
in a time-dependent manner, whereas it remained unchanged in the remainder of PKC isoforms tested (data not shown). To evaluate PKC activation, MRC-5 cells treated with 20% CSE for 0, 0.5, and 1 h were fractionated to isolate membrane and cytosolic fractions, as described in Materials and Methods. Both fractions were immunoblotted with antisera against various PKC isoforms. After 30 min of CSE exposure, the membrane fraction of MRC-5 exhibited increased PKC
and
(Fig. 4B) as well as PKC
and
(data not shown), indicating activation of these PKC isoforms by CSE exposure. The remainder of PKC isoforms tested did not show expression in the membrane fraction (data not shown).
|
Next, we investigated the relative role of PKC
and PKC
on DISC formation in the CSE-induced extrinsic apoptotic pathway. MRC-5 at 30% confluence were infected with adenovirus containing cDNAs for LacZ, or dnPKC
for 48 h, and exposed to 20% CSE for 0, 1, 3, and 6 h. The DISC formed in both dnPKC
and LacZ-infected cells subjected to CSE, with a maximum at 1 h (Fig. 5A). However, DISC formation in response to CSE was increased in cells infected with dnPKC
relative to LacZ-infected cells (Fig. 5A). To obtain fluorescent images at a single cell level, MRC-5 cells triple-labeled with Fas, caspase-8, and GRASP65 were analyzed after 1 h CSE treatment. The cyan pseudocolor in the merged images indicates a colocalization of Fas and caspase-8, showing a stronger fluorescent signal in the cells infected with dnPKC
compared with LacZ-infected cells (Fig. 5B), consistent with the biochemical observations (Fig. 5A). DISC-positive cells were increased in dnPKC
-infected cells (73%) compared with LacZ-infected cells (45%) (n = 45–55). We assessed the effect of PKC
on CSE-induced cell death, using the MTT assay. MRC-5 infected with dnPKC
had lower viability after CSE challenge relative to the LacZ-infected cells (Fig. 5C). Consistent with the observation in Fig. 5A, DISC formation was markedly diminished in PKC
-infected cells relative to that observed in LacZ-infected cells (Fig. 5D). Consequently, PKC
-infected cells were more resistant to CSE exposure (Fig. 5E). The efficiency of adenoviral infection was determined in LacZ-infected cells by monitoring β-galactosidase activity (Fig. 5F).
|
on CSE-induced apoptosis, MRC-5 cells were infected with dnPKC
, and its effect on CSE-induced DISC formation was assessed. The DISC formation in MRC-5 infected with dnPKC
was decreased relative to LacZ-infected cells (Fig. 6A). Single-cell fluorescent imaging of CSE-treated MRC-5 cells triple-labeled with anti-GRASP65, anti-caspase-8, and anti-Fas demonstrated the formation of DISC (i.e., colocalized distribution of caspase-8 and Fas) in only 13% of dnPKC
-expressing cells compared with 46% in the LacZ control (n = 47 for dnPKC
, n = 52 for LacZ control) (Fig. 6B). We also assessed the effect of PKC
on CSE-induced loss of cell viability using the MTT assay. MRC-5 infected with dnPKC
displayed increased cell survival relative to the LacZ-infected cells after CSE exposure (Fig. 6C). In contrast, cell death was increased in PKC
-infected cells compared with LacZ-infected cells (Fig. 6D). Additionally, the activation of caspase-3 during CSE treatment of MRC-5 was increased in dnPKC
-infected cells, but it decreased in dnPKC
-infected cells, compared with LacZ-infected cells (Fig. 6E).
|
PKC
and
differentially modulate Akt phosphorylation at Ser473
The PI3K/Akt pathway is an important determinant of apoptosis and survival in many cell types. Phosphorylation of Akt at Ser473 is critical for preventing activation-induced apoptosis (32). Because our studies showed differential effects of PKC
and PKC
on CSE-induced DISC formation and apoptotic cell death, we hypothesized that the two PKC isoforms would also differentially regulate activation of Akt. To evaluate the effect of PKC
and PKC
on Akt phosphorylation, MRC-5 were infected with dnPKC
, dnPKC
, or LacZ, exposed to 20% CSE for 1 h, and followed by immunoblotting analysis for Akt activation as shown in Fig. 7A. Akt phosphorylation on Ser473 was reduced in dnPKC
-infected cells compared with LacZ-infected cells, whereas Akt phosphorylation was increased in dnPKC
-infected cells. Next, we studied the involvement of the PI3K/Akt pathway on DISC formation using the PI3K inhibitor wortmannin. The PI3K inhibitor significantly increased DISC formation after 1 h CSE exposure (Fig. 7B). These data suggest that the mechanism by which PKC
and PKC
differentially regulate the DISC formation is mediated by the PI3K/Akt pathway.
|
and PKC
regulate CSE-induced cell death in vivo
Finally, we evaluated the role of PKC
in an in vivo model of smoke exposure. Mice were infected with adenovirus containing PKC
or LacZ and exposed to CS for 4 wk. Mice infected with PKC
displayed diminished DISC formation in total lung tissue, relative to LacZ-infected mice, as detected by immunoprecipitation of lung homogenates with Fas followed by immunoblotting with caspase-8 (Fig. 8, A and B). Additionally, diminished caspase-8 and caspase-3 activation were detected in lung tissue of the CS-exposed mice infected with PKC
relative to LacZ-infected controls (Fig. 8C). The antiapoptotic effect of PKC
in vivo was confirmed by TUNEL staining. Lung tissue from PKC
-infected mice displayed a diminished number of TUNEL-positive cells relative to LacZ-infected controls after 4 wk of CS exposure (Fig. 8D). H&E staining (Fig. 8E) clearly shows that PKC
-infected mice were protected against lung injury in response to 4 wk CSE. Lungs from PKC
-infected smoke-exposed mice showed similar histology as their sham-exposed counterparts or as LacZ-infected wild-type mice. In contrast, LacZ-infected mice showed clear histological indication of lung injury after 4 wk CSE.
|
and exposed to cigarette smoke for 4 wk. As shown in Fig. 8F, PKC
infection augmented the activation of caspase-3 in lung tissue in response to cigarette smoke exposure, relative to LacZ-infected mice. | Discussion |
|---|
|
|
|---|
Since the ligand for Fas (FasL) is extracellular, Fas membrane trafficking must occur for maximal signaling (16, 17, 38), a critical parameter in determining the ability of the cell to undergo apoptosis (39). Fas, however, can also be activated in a ligand-independent fashion (40), resulting in DISC formation and activation of caspase-8, which subsequently triggers a downstream signaling cascade that culminates in apoptosis. Previous studies reported that activation of membrane Fas leads to the recruitment of FADD and caspase-8 to lipid rafts in mouse thymocytes (41), human CD4+ T cells (27), and human lymphoblastoid CEM cells (28). In contrast, we demonstrated that intracellular assembly of the DISC occurs first within the Golgi complex before its translocation to the lipid rafts (Fig. 3). These results suggest that the Golgi-associated DISC forms independently of FasL and translocates to the plasma membrane where FasL-mediated apoptosis may be initiated and amplified. We previously observed similar Golgi-to-plasma membrane translocation of the DISC in mouse lung endothelial cells subjected to hypoxia-reoxygenation stress (20, 42).
The DISC, which represents the apical event in the extrinsic apoptotic pathway, is subject to multiple regulatory mechanisms, including transcription factors such as NF-
B, AP-1, Stat-3 (43, 44), and the PI3K/Akt signaling pathway (45). Inhibition of JNK or PKC can abolish Fas/CD95-tyrosine phosphorylation, which in turn reduces Fas membrane trafficking and DISC formation (38). The protein-tyrosine phosphatase FAP-1 can suppress Fas trafficking to the cell surface (39, 46, 47), whereas dynamin-2 facilitates Fas translocation by protein–protein interaction (48), implicating that Fas-tyrosine phosphorylation is required for the DISC formation. We have previously shown that DISC formation during hypoxia-reoxygenation-induced endothelial cell apoptosis was inhibited by expression of the endogenous caspase-8 inhibitor FLIP (42) and of Bcl-XL (20). We also reported that DISC formation during hyperoxia-induced endothelial cell apoptosis depended on reactive oxygen species generation, and could be inhibited by carbon monoxide, as well as by inhibitors of ERK1/2 MAPK or NADPH oxidase-dependent pathways (49).
Previous studies have demonstrated that PKCs do not modulate the expression levels of Fas (50, 51) or FADD (51). Furthermore, modulation of FADD phosphorylation state by PMA had no effect on the affinity of FADD for either the Fas DISC (52, 53) or the TRAIL DISC (54). The relative role of individual PKC isoforms in Fas-mediated apoptosis and DISC formation remains unclear. Little is known about the expression or activation state of PKCs in response to CSE exposure, or about their roles in CSE-induced apoptosis. CSE induced the plasma membrane translocation of PKC, which preferentially involved the PKC
,
(Fig. 4B),
, and
isoforms. Of these active forms, PKC
, a conventional PKC, has been implicated as a regulator of many processes associated with apoptosis in lung cells (42, 55). In our current study, we focused on the effects of PKC
and
in CSE-induced apoptosis. Further studies may be required to elucidate the roles of PKC
or PKC
.
The results of the current study suggest that PKC
and PKC
, which are both activated by cigarette smoke, exert opposing effects on apoptosis. Since apoptosis is induced by CSE in wild-type cells, we hypothesize that proapoptotic processes, including the influence of PKC
, are dominant under these conditions. Consistent with this hypothesis, adenoviral-mediated expression in vitro and in vivo of PKC
protected against cell death and lung injury in response to CSE, whereas expression of PKC
promoted cell death and lung apoptosis (Figs. 5, 6, and 8). We showed that inhibition of PKC
with a dominant negative mutant augmented CSE-dependent DISC formation and cell death (Fig. 5C), whereas expression of PKC
inhibited DISC formation. This result is consistent with previous studies that PMA-induced PKC, mostly representing activation of conventional PKCs, protected against apoptosis. PMA treatment inhibited TRAIL-induced cytotoxicity by decreasing the recruitment of key obligatory death domain-containing adaptor proteins (54), and it also inhibited Fas binding to FADD in Jurkat cells (52). In contrast, we observed that PKC
exerted the opposite effect of PKC
in CSE-induced DISC formation. This apparent proapoptotic effect of PKC
in the current model contrasts with several previous studies. For example, PKC
inhibited DISC formation in acute myeloid leukemia cells, possibly through phosphorylating FADD (56), as well as in Jurkat cells during FasL-induced apoptosis (51). In contrast, PKC
exerted a propapoptotic signaling role in rat hepatocytes, whereby PKC
mediated the ceramide-dependent activation of NADPH oxidase, leading to DISC formation, in response to FasL stimulation (40).
The mechanism(s) by which PKC
and
regulate DISC formation in the CSE-induced apoptosis model remain unclear; however, the experiments (Fig. 7) strongly suggest a role for the prosurvival PI3K/Akt pathway. An interaction between PKCs and the Akt pathway was previously reported to occur during UV light-induced apoptosis, where PKC
inhibited Akt function, whereas PKC
enhanced the phosphorylation of Akt on Ser473 (57). In the present study, the introduction of dnPKC
reduced, whereas dn PKC
increased, Akt phosphorylation (Fig. 7A). Furthermore, DISC formation in response to CSE was significantly increased in wortmannin-treated cells (Fig. 7B), suggesting that the opposing effects of these PKCs may be at least in part attributable to Akt phosphorylation status.
Interestingly, the lipid-derived apoptosis mediator ceramide can regulate PKCs in several systems. Ceramide inhibited PKC
without altering PKC
protein levels (58). In lung endothelial cells, CS induced a rapid, sustained ceramide up-regulation (59). Lung ceramide levels were also markedly higher in subjects with emphysema from chronic cigarette smoking (59). We speculate that CS may inhibit the antiapoptotic role of PKC
in vivo through ceramide generation. In contrast, PKC
is activated in vitro by ceramide, as well as in National Institutes of Health 3T3 fibroblasts treated with sphingomyelinase (60). Given that relationships between ceramide generation (as observed in chronic smokers and in vitro) and PKC regulation have been observed, we hypothesized that both PKC
and PKC
may modulate apoptotic phenotypes in vivo in the context of chronic smoke exposure. Accordingly, we demonstrated that expression of PKC
in vivo reduced lung cell apoptosis in response to prolonged cigarette smoke exposure. Specifically, PKC
expression inhibited DISC formation, caspase-8/caspase-3 activation, and histological indications of tissue injury and apoptosis in smoke-exposed lung, whereas PKC
augmented caspase-3 activation in smoke-exposed lung.
The focus of the present paper is to characterize the apoptotic responses of lung fibroblasts in response to cigarette smoke. The lung is a heterogeneous organ consisting of multiple cell types including fibroblasts of the lung parenchyma, as well as bronchial, airway, and alveolar epithelial cells, endothelial and smooth muscle cells of the pulmonary vasculature, smooth muscles of the airway, alveolar macrophages, and other specialized cells (such as mast cells). We cannot exclude the possibility that apoptotic responses in other cell types may have an equal or perhaps greater contribution to the pathogenesis of pulmonary illnesses triggered by cigarette smoke. We chose in the present study to perform a detailed mechanistic study of apoptosis in one cell type (fibroblasts). The characterization of apoptotic responses and mechanisms in all of the cell types of the lung is beyond the scope of this paper. We have, however, conducted in vivo experiments to extrapolate the findings to total lung tissue (Fig. 8.) We show that expression of PKC isoforms in vivo differentially modulate apoptosis and tissue injury in the lungs of chronic cigarette smoke-exposed mice.
We have observed that cigarette smoke induces DISC formation and caspase-8 activation in human bronchial epithelial cells (Beas-2B) (X. Wang, H. P. Kim, M. H. Huang, S. W. Ryter, and A. M. Choi, unpublished observations), which is consistent with the fibroblast results. Further experimentation is warranted to determine activation profiles of PKC isoforms in other cell types such as epithelial cells.
We also evaluated the expression of PKC isoforms in human clinical samples with COPD relative to that of normal control lung. The expression of PKC
and PKC
were elevated in COPD, with dominant expression of the proapoptotic isoform PKC
at advanced stages of disease progression (data not shown).
In conclusion, our observations have several important implications for CSE-induced apoptosis. First, we demonstrate that CSE induces intracellular DISC formation in MRC-5 cells, involving the recruitment of procaspase-8 and FADD to Fas within the cytosolic Golgi compartment. This event appears to represent a prerequisite for translocation of the preformed DISC to the lipid rafts, and it likely occurs in a FasL-independent fashion. Thus, the appearance of DISC in the lipid raft may represent the initial event in a FasL-independent extrinsic apoptosis pathway triggered by CSE, although it may also serve to facilitate subsequent FasL-induced apoptosis. Second, our results indicate that PKC activation modulates DISC assembly at the level of recruitment of procaspase-8 to Fas, providing additional insight into the mechanisms underlying CSE-induced Fas-mediated apoptosis. Furthermore, our data support the view that distinct PKC isoforms may have differential effects on DISC formation (40, 48, 50, 51, 52, 53, 54, 56). The phosphorylation status of Akt may partly affect the DISC formation. We cannot exclude, however, that PKCs may regulate DISC formation by modulating the phosphorylation state of other DISC components. We have also shown that PKC isoforms can differentially modulate lung injury and cell death in vivo. Finally, our data suggest that PKC-modulating compounds may be useful tools for regulating apoptosis, and furthermore, that they may have potential applications in CS-related diseases that have limited therapeutic options at present.
| Acknowledgments |
|---|
| Disclosures |
|---|
|
|
|---|
| Footnotes |
|---|
1 This work was supported in part by awards from the American Heart Association (0335035N to S.W.R and 0525552U to H.P.K.), National Institutes of Health Grant K08AI51402 and United States Immune Deficiency Network subcontract from National Institute of Allergy and Infectious Disease, National Institutes of Health (to Y.M.V.), and National Institutes of Health Grants R01HL60234, R01HL55330, R01HL079904, and P01HL70807 (to A.M.K.C.). ![]()
2 Address correspondence and reprint requests to Dr. Augustine M. K. Choi, Pulmonary and Critical Care Medicine, Brigham and Womens Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115. E-mail address: amchoi{at}rics.bwh.harvard.edu or Dr. Yatin M. Vyas, Division of Pediatric Hematology-Oncology, Childrens Hospital of Pittsburgh, 3705 Fifth Avenue, Pittsburgh, PA 15213. E-mail address: yatin.vyas{at}chp.edu ![]()
3 Abbreviations used in this paper: COPD, chronic obstructive pulmonary disease; CS, cigarette smoke; CSE, cigarette smoke extract; DISC, death-inducing signaling complex; dn, dominant negative; FADD, Fas-associated protein with death domain; FasL, Fas ligand; LDH, lactate dehydrogenase; PKC, protein kinase C. ![]()
Received for publication August 13, 2007. Accepted for publication January 27, 2008.
| References |
|---|
|
|
|---|
induces Fas trafficking and sensitization to apoptosis in vascular smooth muscle cells via a PI3K- and Akt-dependent mechanism. Am. J. Pathol. 168: 2054-2063.
in Fas/Fas ligand-mediated apoptosis. J. Immunol. 178: 312-319.
and
isoforms of protein kinase C. Mol. Cell. Biol. 18: 5199-5207.
B p50–p65 recruitment. Mol. Cell. Biol. 19: 2098-2108.
isoform in Fas resistance of immature myeloid KG1a leukemic cells. Blood 98: 3770-3777. This article has been cited by other articles:
![]() |
C.-M. Yang, I-T. Lee, C.-C. Lin, Y.-L. Yang, S.-F. Luo, Y. R. Kou, and L.-D. Hsiao Cigarette smoke extract induces COX-2 expression via a PKC{alpha}/c-Src/EGFR, PDGFR/PI3K/Akt/NF-{kappa}B pathway and p300 in tracheal smooth muscle cells Am J Physiol Lung Cell Mol Physiol, November 1, 2009; 297(5): L892 - L902. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |